Saba Kiremitçi

416 total citations
42 papers, 266 citations indexed

About

Saba Kiremitçi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Saba Kiremitçi has authored 42 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Nephrology. Recurrent topics in Saba Kiremitçi's work include Renal Diseases and Glomerulopathies (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Complement system in diseases (4 papers). Saba Kiremitçi is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Liver Disease Diagnosis and Treatment (6 papers) and Complement system in diseases (4 papers). Saba Kiremitçi collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Saba Kiremitçi's co-authors include Arzu Ensarı, Sevim Güllü, Esra Erden, Berna İmge Aydoğan, Rovshan Hasanov, Duygu Kankaya, Ayşe Sertçelik, Salih Taşkın, Özden Tulunay and Sümer Baltacı and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Journal of Hepatology.

In The Last Decade

Saba Kiremitçi

36 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saba Kiremitçi Türkiye 10 76 60 57 54 52 42 266
Jisu Oh South Korea 10 170 2.2× 52 0.9× 103 1.8× 93 1.7× 44 0.8× 24 429
Han-Seong Kim South Korea 9 111 1.5× 48 0.8× 72 1.3× 93 1.7× 52 1.0× 13 330
Jun Zou China 13 143 1.9× 138 2.3× 39 0.7× 54 1.0× 24 0.5× 27 400
Chun-Gyoo Ihm South Korea 11 107 1.4× 199 3.3× 48 0.8× 49 0.9× 31 0.6× 16 428
Izabella Czajka-Oraniec Poland 8 46 0.6× 64 1.1× 45 0.8× 104 1.9× 51 1.0× 17 352
Shun Manabe Japan 11 81 1.1× 204 3.4× 53 0.9× 40 0.7× 50 1.0× 42 368
Holly Hutton Australia 7 171 2.3× 128 2.1× 48 0.8× 32 0.6× 36 0.7× 12 341
Shenglei Zhang China 12 161 2.1× 94 1.6× 43 0.8× 22 0.4× 33 0.6× 43 348
Takayuki Sugai Japan 9 99 1.3× 61 1.0× 72 1.3× 31 0.6× 61 1.2× 16 312
Lin Liao China 11 80 1.1× 34 0.6× 57 1.0× 53 1.0× 36 0.7× 22 313

Countries citing papers authored by Saba Kiremitçi

Since Specialization
Citations

This map shows the geographic impact of Saba Kiremitçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saba Kiremitçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saba Kiremitçi more than expected).

Fields of papers citing papers by Saba Kiremitçi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saba Kiremitçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saba Kiremitçi. The network helps show where Saba Kiremitçi may publish in the future.

Co-authorship network of co-authors of Saba Kiremitçi

This figure shows the co-authorship network connecting the top 25 collaborators of Saba Kiremitçi. A scholar is included among the top collaborators of Saba Kiremitçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saba Kiremitçi. Saba Kiremitçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göğüş, Çağatay, et al.. (2025). Assessment of the Impact of Grade Heterogeneity on Survival in Ta and T1 Tumors: A Subgroup Analysis of NMIBC Cohort. Clinical Genitourinary Cancer. 23(4). 102357–102357. 1 indexed citations
2.
Gümüşsoy, Mesut, Saba Kiremitçi, Fatih Karakaya, et al.. (2024). FRI-238 Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy. Journal of Hepatology. 80. S479–S479.
3.
Öz, Diğdem Kuru, Mesut Gümüşsoy, Saba Kiremitçi, et al.. (2024). Assessing hepatic steatosis by magnetic resonance in potential living liver donors. Diagnostic and Interventional Radiology. 0(0). 0–0. 2 indexed citations
4.
Erul, Enes, et al.. (2024). Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature. Medicina. 60(12). 1918–1918. 1 indexed citations
5.
Çakiroğlu, Funda Pınar, et al.. (2022). Inulin may prevent steatosis by suppressing cannabinoid receptor-1 and patatin-like phospholipase-3 expression in liver. Nutrition. 103-104. 111742–111742. 6 indexed citations
6.
Bostancı, Seher, et al.. (2021). Superficial Acral Fibromyxoma. Journal of the American Podiatric Medical Association. 111(5). 1 indexed citations
7.
Akar, Ece, Zeynep Birsin Özçakar, Nilgün Çakar, et al.. (2021). Infantile systemic lupus erythematous presenting as nephrotic syndrome in a 12-month-old boy: a case report. The Turkish Journal of Pediatrics. 63(2). 339–343.
8.
Demir, Arzu Meltem, Fatma Aydın, Banu Çelikel Acar, et al.. (2021). IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review. Clinical Rheumatology. 40(9). 3817–3825. 7 indexed citations
9.
Kiremitçi, Saba, et al.. (2020). Duodenal bulb biopsy in the diagnostic work-up of coeliac disease. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(4). 507–515. 1 indexed citations
10.
Kiremitçi, Saba, et al.. (2020). Gastric and small intestinal traditional serrated adenomas: a detailed morphologic and immunohistochemical analysis. The Turkish Journal of Gastroenterology. 31(6). 441–450. 5 indexed citations
11.
Kiremitçi, Saba, et al.. (2020). Two patients, two viruses and multiple sites of injury in the kidney. Journal of Nephrology. 34(1). 263–265. 1 indexed citations
12.
Hasanov, Rovshan, Berna İmge Aydoğan, Saba Kiremitçi, Esra Erden, & Sevim Güllü. (2019). The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas. Endocrine Pathology. 30(1). 49–55. 38 indexed citations
13.
Başaran, Özge, Nermin Uncu, Nilgün Çakar, et al.. (2018). C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review. Rheumatology International. 38(8). 1571–1576. 12 indexed citations
14.
Kiremitçi, Saba, Neval Duman, Kenan Ateş, et al.. (2017). Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes. Kidney & Blood Pressure Research. 42(5). 886–893. 31 indexed citations
15.
Gür, Gökçe, et al.. (2016). Hemorragia pulmonar, una complicación poco frecuente en una niña con púrpura de Schönlein-Henoch. Archivos Argentinos de Pediatria. 114(5). e366–9. 1 indexed citations
16.
Kankaya, Duygu, Saba Kiremitçi, Özden Tulunay, & Sümer Baltacı. (2015). Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome. Pathology - Research and Practice. 211(7). 505–512. 14 indexed citations
17.
Neşe, Nalan, Banu Sarsık, Dilek Ertoy Baydar, et al.. (2015). Small Cell Carcinomas of the Bladder Highly Express Somatostatin Receptor Type 2A. Applied immunohistochemistry & molecular morphology. 24(4). 253–260. 4 indexed citations
18.
Kiremitçi, Saba, et al.. (2012). Pathologist's puzzle: Membranoproliferative glomerulonephritis-like features in cryoglobulinemic glomerulonephritis. Pathology - Research and Practice. 208(4). 254–258. 3 indexed citations
19.
Kahraman, Korhan, Saba Kiremitçi, Salih Taşkın, et al.. (2012). Expression pattern of PAX2 in hyperplastic and malignant endometrium. Archives of Gynecology and Obstetrics. 286(1). 173–178. 12 indexed citations
20.
Kiremitçi, Saba, et al.. (2011). A presacral dermoid cyst with extremely high serum CA19-9 level. Journal of Obstetrics and Gynaecology. 32(1). 103–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jisu Oh Breakdown of academic impact, for papers by Han-Seong Kim Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Chun-Gyoo Ihm Breakdown of academic impact, for papers by Izabella Czajka-Oraniec Breakdown of academic impact, for papers by Shun Manabe Breakdown of academic impact, for papers by Holly Hutton Breakdown of academic impact, for papers by Shenglei Zhang Breakdown of academic impact, for papers by Takayuki Sugai Breakdown of academic impact, for papers by Lin Liao
Rankless by CCL
2026